Antag Therapeutics is a startup based in Denmark, most recent round Series A, 1 tracked investor.
Antag Therapeutics is a startup founded in 2023 based in Denmark. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Antag Therapeutics is a biopharmaceutical company focused on developing treatments for obesity and related metabolic disorders through GIP receptor antagonism. Its lead candidate, AT7687, is a first-in-class peptide-based therapy designed to block biological pathways contributing to fat storage and insulin resistance.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.